Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants

NCT02596958 · clinicaltrials.gov ↗

COMPLETED

Status

996

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Interventions

DRUG: Bevacizumab

Sponsor

Hoffmann-La Roche